Automated insulin delivery (AID) systems are transforming how people with Type 1 diabetes manage their condition, offering tighter glucose control and more freedom in daily life. Yet, access to this ...

Medicaid coverage is state-dependent. Some states provide CGMs with no cost-sharing, while others limit eligibility to Type 1 ...

Abbott (NYSE: ABT), a global healthcare leader, announced today it has secured CE Mark for the world's first dual ...

Please provide your email address to receive an email when new articles are posted on . Diabetes technologies have been evolving rapidly in recent years and now serve a wide range of patients. Usage ...

Diabetes is a chronic disease characterised by a failure of insulin to control blood glucose levels with two main types: type 1 and type 2. Diabetes is a global concern, with 783 million adults ...

Does diabetes affect the immune system? Both Type 1 and Type 2 diabetes affect millions of people around the world, although many who suffer from it have not been officially diagnosed with the disease ...

Small practices reduced their use of telemedicine during early stages of the COVID-19 pandemic. Technical support may help expand and maintain telemedicine in small practices. Objectives: The COVID-19 ...

A novel diabetes management system that used artificial intelligence (AI) to recommend personalized lifestyle changes helped people with type 2 diabetes and obesity de-escalate glucose-lowering ...

North Chicago-based Abbott announced it has established a partnership with Omada Health, which will integrate Abbott's Freestyle Libre Type 2 diabetes monitoring system into Omada's digital care ...

Researchers at Stanford Medicine have reported a breakthrough in Type 1 diabetes research after successfully curing the ...

A combination blood stem cell and pancreatic islet cell transplant from an immunologically mismatched donor completely prevented or cured Type 1 diabetes in mice in a study by Stanford Medicine ...

Surpass-Early randomized ~800 adults with ≤4-year type 2 diabetes on metformin to add tirzepatide or intensify care, predominantly with semaglutide or dulaglutide comparators. At two years, ...